{"id":"W1971335911","doi":"10.1200/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Oncology; Tamoxifen; Everolimus; Aromatase inhibitor; Internal medicine; Estrogen receptor; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1704621,0.001770359,0.005769027,0.005314234,0.001107236,0.0139861,0.004894899,0.003144467,0.003095976],"category_scores_gemma":[0.292956,0.001150446,0.003054911,0.004965318,0.003285587,0.01126961,0.004817483,0.007872392,0.001077349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00592868,"about_ca_system_score_gemma":0.01144304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002474705,"about_ca_topic_score_gemma":0.003948432,"domain_scores_codex":[0.8535535,0.1131845,0.01682569,0.004567405,0.01102285,0.0008460392],"domain_scores_gemma":[0.6824499,0.2330892,0.03021781,0.01127621,0.03802714,0.004939795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001516326,0.0002252865,0.01384958,0.01571103,0.003489509,0.00006202827,0.0007401266,0.00600656,0.0004354377,0.02395237,0.03962463,0.8943871],"study_design_scores_gemma":[0.005862628,0.005606817,0.04810598,0.09823742,0.01195976,0.001040662,0.003383946,0.1021937,0.002381518,0.3081651,0.4121784,0.0008840577],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.01836395,0.5493688,0.1326302,0.275041,0.006017164,0.003132006,0.001533046,0.001086893,0.01282693],"genre_scores_gemma":[0.3122467,0.1782832,0.4390813,0.05316499,0.007442957,0.005110469,0.002372,0.0006840248,0.00161435],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.1704621,"threshold_uncertainty_score":0.9015005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07697496632451407,"score_gpt":0.4536372477676764,"score_spread":0.3766622814431623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}